AnalystBook Research · Company Intelligence

AXT INC

AXTINasdaq

Built from AXT INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

AXT sales fell, losses widened, cash burn worsened, equity rose, and insider activity was sales-only.

The read at a glance✓ Audited against SEC data
  • Business mixCompound semiconductor substrates and raw materialsNote
  • RevenueRevenue fell 11.1%Watch
  • LossesNet loss widened to $21.3MWatch
  • CashFree cash flow worsened to -$18.8MWatch
  • Balance sheetEquity rose 41.8%OK
  • Insiders0 buys / 34 sellsWatch
  • AccountingAltman-Z grey; other screens safeNote

Business

AXT makes high-performance compound and single-element semiconductor substrates and sells related raw materials.

Where the revenue comes from

Fiscal 2025, as AXT INC reports it. History and quarterly detail are in the app.

  • Substrates$58.9M
  • Raw Materials and Other$29.4M

Leadership changes

From AXT INC's own filings, the day they're filed.

  • Leonard J. LeBlanc · directors · appointmenteff. 2025-07-29
  • Leonard J. Leblanc · directors · appointmenteff. 2025-07-29
  • Jesse Chen · Chair of the Audit Committee · appointmenteff. 2025-07-29

Latest filings

  • 10-Q · Quarterly report2026-08-13
  • 8-K · Company announcement2026-07-30
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-07-22
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about AXT INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.